Bryant Moeller The 6-minute pegboard and ring test (6PBRT) can be used as a valid and reliable test to evaluate functional arm exercise capacity in patients with well-controlled asthma, according…
Research – Open Access Yuqing Mo, Ling Ye, Hui Cai, Guiping Zhu, Jian Wang, Mengchan Zhu, Xixi Song, Chengyu Yang & Meiling Jin Abstract Background Serine peptidase inhibitor, clade B, member 10 (SERPINB10) contributes to allergic inflammation in asthma.…
Research – Open Access Aleksandra Wardzyńska, Małgorzata Pawełczyk, Joanna Rywaniak, Joanna Makowska, Joanna Jamroz-Brzeska & Marek L. Kowalski Respiratory Research volume 22, Article number: 177 (2021) Abstract Background The course of asthma may differ between elderly asthmatics (EA) and non-elderly asthmatics…
Self-monitoring using a digital platform and remote clinician feedback helped patients maintain adherence to inhaled corticosteroids and decreased short-acting beta agonist use, researchers reported. “Poor adherence to inhaled corticosteroid-containing medications and overreliance…
Research – Open Access Mustafa Abdo, Mohib Uddin, Torsten Goldmann, Sebastian Marwitz, Thomas Bahmer, Olaf Holz, Anne-Marie Kirsten, Frederik Trinkmann, Erika von Mutius, Matthias Kopp, Gesine Hansen, Klaus F. Rabe, Henrik Watz, Frauke Pedersen on behalf of the ALLIANCE study group Respiratory Research volume 22, Article number: 167 (2021) Abstract…
Research Open Access Maria E. Ramos-Nino, Charles D. MacLean & Benjamin Littenberg Asthma Research and Practice volume 7, Article number: 6 (2021) Abstract Background The association of obesity with the development of obstructive lung disease, namely asthma and/or…
Research – Open Access David Lamb, Dorothy De Sousa, Karsten Quast, Katrin Fundel-Clemens, Jonas S. Erjefält, Caroline Sandén, Hans Jürgen Hoffmann, Marc Kästle, Ramona Schmid, Kevin Menden & Denis Delic Respiratory Research volume 22, Article number: 158 (2021) Abstract Background RORγt is a transcription factor that…
Brian Park, PharmD The Biologics License Application (BLA) for tezepelumab has been submitted to the Food and Drug Administration (FDA) for patients with severe asthma. Tezepelumab is an investigational first-in-class…
Research – Open Access Bingqing Shi, Wei Li, Yuqiu Hao, Hongna Dong, Wenjing Cao, Jie Guo & Peng Gao Allergy, Asthma & Clinical Immunology volume 17, Article number: 47 (2021) Abstract Background There is a need to identify the asthma inflammatory phenotypes…